Tortugas Neuroscience Launches with $106 Million to Advance Clinical Stage Pipeline Targeting New and Major Neurology and Neuropsychiatric Disorders
Biotech Veterans Jeff Jonas and Al Robichaud to Lead Company with Investment from
Cure Ventures, The Column Group, and AN Ventures